The Food and Drug Administration (FDA) has expanded the availability of the COVID-19 vaccine booster shots in the wake of new data showing the Omicron variant can bypass protection provided by the first two doses.
The agency announced Thursday that it has expanded the eligibility of the Pfizer-BioNTech booster for people 16 and 17 years old.
It is the youngest age group to become eligible for the booster shot in America.
All Americans in the age group will be able to receive the additional shot six months after completion of their initial vaccine series.
On Wednesday, Pfizer unveiled data showing that people who had received only the first two-shots were vulnerable to the Omicron variant, but that the third shot could return protection back to original levels.
This is a breaking news story and will be updated
Source: | This article originally belongs to Dailymail.co.uk
Original Article
